Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10009-10014
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10009
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10009
Table 1 Prescription of antithrombotic agents
Anticoagulants | n |
Warfarin | 68 |
Dabigatran | 12 |
Rivaroxaban | 3 |
Antiplatelets | |
Aspirin | 93 |
Clopidogrel | 35 |
Cilostazol | 31 |
Ticlopidine | 12 |
Others | 28 |
Anticoagulants + antiplatelets | 28 |
Dual antiplatelets | 59 |
Triple antiplatelets | 8 |
Heparin bridge | 73 |
Table 2 Characteristics of the study cohort and polyps n (%)
No bleeding | Bleeding | P value | ||
No. of patients | 759 (96.3) | 29 (3.7) | ||
Age (yr, mean) | 64 ± 14.3 | 62 ± 16.0 | 0.50 | |
Gender | Male | 458 (98.1) | 9 (1.9) | 0.35 |
Female | 301 (93.8) | 20 (6.2) | ||
Polyp location | Right | 239 (95.6) | 11 (4.4) | 0.93 |
Left | 336 (95.5) | 16 (4.5) | ||
Polyp size | ≥ 10 mm | 338 (96.8) | 11 (3.2) | 0.43 |
< 10 mm | 361 (95.8) | 16 (4.2) | ||
Polyp shape | Flat | 266 (96.7) | 9 (3.3) | 0.73 |
Sessile | 416 (96.5) | 15 (3.5) | ||
Pedunculated | 118 (95.2) | 6 (4.8) | ||
No. of polyps resected | 1 | 343 (96.6) | 12 (3.4) | 0.69 |
≥ 2 | 416 (96.1) | 17 (3.9) | ||
Prophylactic clipping | Yes | 566 (95.8) | 25 (4.2) | 0.16 |
No | 193 (98.0) | 4 (2.0) | ||
Resection method | Polypectomy or EMR | 703 (96.6) | 25 (3.4) | 0.20 |
ESD | 56 (93.3) | 4 (6.7) | ||
Antiplatelets | Yes | 146 (94.8) | 8 (5.2) | 0.27 |
No | 613 (96.7) | 21 (3.3) | ||
Anticoagulants | Yes | 72 (86.7) | 11 (13.3) | < 0.001 |
No | 687 (97.4) | 18 (2.6) | ||
Heparin bridge | Yes | 63 (86.3) | 10 (13.7) | < 0.001 |
No | 696 (97.3) | 19 (2.7) | ||
Antiplatelets + heparin bridge | Yes | 32 (91.4) | 3 (8.6) | 0.11 |
No | 727 (96.5) | 26 (3.5) | ||
Anticoagulants + heparin bridge | Yes | 47 (82.5) | 10 (17.5) | < 0.001 |
No | 712 (97.4) | 19 (2.6) |
Table 3 Multivariate analysis of risk factors for Post-polypectomy bleeding
Variable | Odds ratio | 95%CI | P value |
Anticoagulants | 4.227 | 1.126-15.872 | 0.033 |
Heparin bridge therapy | 2.172 | 0.556-8.482 | 0.265 |
Anticoagulants+ heparin bridge | 9.796 | 3.771-25.443 | < 0.001 |
Table 4 Summary of 11 post-polypectomy bleeding cases taking anticoagulants
Anticoagu-lants | Antiplatelets | Heparin | Onset of | PT-INR | Anticoagulants | APTT | Heparin | |
bridge | PPB (POD) | at PPB | at PPB | at PPB | at PPB | |||
1 | Warfarin | Clopidogrel | Yes | 5 | 1.62 | Yes | 93.1 | Yes |
2 | Warfarin | - | Yes | 2 | 1.31 | Yes | 42.8 | Yes |
3 | Warfarin | - | Yes | 6 | 1.26 | Yes | 32.2 | No |
4 | Warfarin | Aspirin | Yes | 2, 5 | 1.20 | Yes | 29.4 | Yes |
5 | Warfarin | - | Yes | 5 | 1.25 | Yes | 73.1 | Yes |
6 | Dabigatran | - | No | 2 | 2.03 | - | - | - |
7 | Warfarin | - | Yes | 1, 2 | 1.31 | No | 45.2 | Yes |
8 | Dabigatran | - | Yes | 6 | 1.40 | - | 50.1 | No |
9 | Warfarin | - | Yes | 1, 6 | 1.23 | No | 33.5 | Yes |
10 | Warfarin | Aspirin | Yes | 2 | 1.32 | Yes | 40.4 | Yes |
(Continued) | ||||||||
11 | Warfarin | - | Yes | 1 | 1.21 | Yes | 29.5 | Yes |
- Citation: Kubo T, Yamashita K, Onodera K, Iida T, Arimura Y, Nojima M, Nakase H. Heparin bridge therapy and post-polypectomy bleeding. World J Gastroenterol 2016; 22(45): 10009-10014
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10009.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10009